Cancer Research The Future of Cancer Research: Science and Patient Impact Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baird, K.
Right arrow Articles by Meltzer, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baird, K.
Right arrow Articles by Meltzer, P. S.
[Cancer Research 65, 9226-9235, October 15, 2005]
© 2005 American Association for Cancer Research

Molecular Biology, Pathobiology and Genetics

Gene Expression Profiling of Human Sarcomas: Insights into Sarcoma Biology

Kristin Baird1, Sean Davis1, Cristina R. Antonescu3, Ursula L. Harper1, Robert L. Walker1, Yidong Chen1, Arthur A. Glatfelter1, Paul H. Duray2 and Paul S. Meltzer1

1 Cancer Genetics Branch, National Human Genome Research Institute; 2 Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, Maryland; 3 Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York

Requests for reprints: Paul S. Meltzer, National Human Genome Research Institute, NIH, 50 South Drive, Bethesda, MD 20892-8000. Phone: 301-594-5283; Fax: 301-402-3281; E-mail: pmeltzer{at}mail.nih.gov.

Sarcomas are a biologically complex group of tumors of mesenchymal origin. By using gene expression microarray analysis, we aimed to find clues into the cellular differentiation and oncogenic pathways active in these tumors as well as potential biomarkers and therapeutic targets. We examined 181 tumors representing 16 classes of human bone and soft tissue sarcomas on a 12,601-feature cDNA microarray. Remarkably, 2,766 probes differentially expressed across this sample set clearly delineated the various tumor classes. Several genes of potential biological and therapeutic interest were associated with each sarcoma type, including specific tyrosine kinases, transcription factors, and homeobox genes. We also identified subgroups of tumors within the liposarcomas, leiomyosarcomas, and malignant fibrous histiocytomas. We found significant gene ontology correlates for each tumor group and identified similarity to normal tissues by Gene Set Enrichment Analysis. Mutation analysis done on 275 tumor samples revealed that the high expression of epidermal growth factor receptor (EGFR) in certain tumors was not associated with gene mutations. Finally, to further the investigation of human sarcoma biology, we have created an online, publicly available, searchable database housing the data from the gene expression profiles of these tumors (http://watson.nhgri.nih.gov/sarcoma), allowing the user to interactively explore this data set in depth.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
J. M. Lubieniecka, D. R.H. de Bruijn, L. Su, A. H.A. van Dijk, S. Subramanian, M. van de Rijn, N. Poulin, A. G. van Kessel, and T. O. Nielsen
Histone Deacetylase Inhibitors Reverse SS18-SSX-Mediated Polycomb Silencing of the Tumor Suppressor Early Growth Response 1 in Synovial Sarcoma
Cancer Res., June 1, 2008; 68(11): 4303 - 4310.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
W. Ren, B. Korchin, Q.-S. Zhu, C. Wei, A. Dicker, J. Heymach, A. Lazar, R. E. Pollock, and D. Lev
Epidermal Growth Factor Receptor Blockade in Combination with Conventional Chemotherapy Inhibits Soft Tissue Sarcoma Cell Growth In vitro and In vivo
Clin. Cancer Res., May 1, 2008; 14(9): 2785 - 2795.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Riggi, M.-L. Suva, D. Suva, L. Cironi, P. Provero, S. Tercier, J.-M. Joseph, J.-C. Stehle, K. Baumer, V. Kindler, et al.
EWS-FLI-1 Expression Triggers a Ewing's Sarcoma Initiation Program in Primary Human Mesenchymal Stem Cells
Cancer Res., April 1, 2008; 68(7): 2176 - 2185.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
H. Tawbi, D. Thomas, D. R. Lucas, J. S. Biermann, S. M. Schuetze, A. L. Hart, R. Chugh, and L. H. Baker
Epidermal Growth Factor Receptor Expression and Mutational Analysis in Synovial Sarcomas and Malignant Peripheral Nerve Sheath Tumors
Oncologist, April 1, 2008; 13(4): 459 - 466.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
I. Matushansky, E. Hernando, N. D. Socci, T. Matos, J. Mills, M. A. Edgar, G. K. Schwartz, S. Singer, C. Cordon-Cardo, and R. G. Maki
A Developmental Model of Sarcomagenesis Defines a Differentiation-Based Classification for Liposarcomas
Am. J. Pathol., April 1, 2008; 172(4): 1069 - 1080.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C.-H. Lee, I. Espinosa, S. Vrijaldenhoven, S. Subramanian, K. D. Montgomery, S. Zhu, R. J. Marinelli, J. L. Peterse, N. Poulin, T. O. Nielsen, et al.
Prognostic Significance of Macrophage Infiltration in Leiomyosarcomas
Clin. Cancer Res., March 1, 2008; 14(5): 1423 - 1430.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. Perbal, M. Zuntini, D. Zambelli, M. Serra, M. Sciandra, L. Cantiani, E. Lucarelli, P. Picci, and K. Scotlandi
Prognostic Value of CCN3 in Osteosarcoma
Clin. Cancer Res., February 1, 2008; 14(3): 701 - 709.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Lito, B. D. Mets, S. Kleff, S. O'Reilly, V. M. Maher, and J. J. McCormick
Evidence That Sprouty 2 Is Necessary for Sarcoma Formation by H-Ras Oncogene-transformed Human Fibroblasts
J. Biol. Chem., January 25, 2008; 283(4): 2002 - 2009.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
E. C. Torchia, K. Boyd, J. E. Rehg, C. Qu, and S. J. Baker
EWS/FLI-1 Induces Rapid Onset of Myeloid/Erythroid Leukemia in Mice
Mol. Cell. Biol., November 15, 2007; 27(22): 7918 - 7934.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
X. Wan and L. J. Helman
The Biology Behind mTOR Inhibition in Sarcoma
Oncologist, August 1, 2007; 12(8): 1007 - 1018.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. G. Maki, J. K. Wathen, S. R. Patel, D. A. Priebat, S. H. Okuno, B. Samuels, M. Fanucchi, D. C. Harmon, S. M. Schuetze, D. Reinke, et al.
Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002
J. Clin. Oncol., July 1, 2007; 25(19): 2755 - 2763.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
V. H. C. Bramwell
Controversies in Surgical Oncology: Routine Anthracycline-based Adjuvant Chemotherapy for Stage III Extremity Soft Tissue Sarcoma
Ann. Surg. Oncol., April 1, 2007; 14(4): 1254 - 1256.
[Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
V. Saxena, D. Orgill, and I. Kohane
Absolute enrichment: gene set enrichment analysis for homeostatic systems
Nucleic Acids Res., December 2, 2006; 34(22): e151 - e151.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
O. M. Tirado, S. Mateo-Lozano, J. Villar, L. E. Dettin, A. Llort, S. Gallego, J. Ban, H. Kovar, and V. Notario
Caveolin-1 (CAV1) Is a Target of EWS/FLI-1 and a Key Determinant of the Oncogenic Phenotype and Tumorigenicity of Ewing's Sarcoma Cells.
Cancer Res., October 15, 2006; 66(20): 9937 - 9947.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. A. Meza-Zepeda, S. H. Kresse, A. H. Barragan-Polania, B. Bjerkehagen, H. O. Ohnstad, H. M. Namlos, J. Wang, B. E. Kristiansen, and O. Myklebost
Array Comparative Genomic Hybridization Reveals Distinct DNA Copy Number Differences between Gastrointestinal Stromal Tumors and Leiomyosarcomas.
Cancer Res., September 15, 2006; 66(18): 8984 - 8993.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
F. Rossi, I. Ehlers, V. Agosti, N. D. Socci, A. Viale, G. Sommer, Y. Yozgat, K. Manova, C. R. Antonescu, and P. Besmer
Oncogenic Kit signaling and therapeutic intervention in a mouse model of gastrointestinal stromal tumor
PNAS, August 22, 2006; 103(34): 12843 - 12848.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.